IL15 and neoplasm: Bergamaschi et al. recently documented how heterodimeric IL-15 (hetIL-15), a cytokine known to be involved in the growth and activation of CD8+ T cells and NK cells, delays tumor growth in subcutaneous murine MC38 colon carcinoma and TC-1 lung carcinoma models [223].